HEALTH CARE SYSTEM WITH PHYSOSTIQMINE AS ACTIVE INGREDIENT THROUGH SKIN AND PREPARATION THEREOF
PURPOSE: To carry out controlled release of physostigmine for a period of 24 hours by selecting an ester or hydrocarbon compound without any free hydroxyl group or any polyethoxy group as a resin of a polymeric layer and a softner. CONSTITUTION: A component of a pressure-sensitive reservoir layer an...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!